Case number 1:18-cv-02051
AstraZeneca AB et al v. MSN Pharmaceuticals, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 25, 2021 | 91 | Stipulation of Dismissal (2) Docket Text: STIPULATION and Proposed Order of Dismissal With Prejudice, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, RedHill Biopharma Inc.. (Silver, Daniel) Modified on 3/25/2021 (nms). |
| Mar 25, 2021 | 92 | Order (2) Docket Text: SO ORDERED Granting [91] Stipulation and Proposed Order of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 3/25/2021. (nms) |
| Mar 25, 2021 | 93 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,012,469. (Attachments: # (1) Order)(nms) |
| Mar 25, 2021 | 93 | Order (2) |
| Dec 22, 2020 | 90 | Notice of Change of Address (2) Docket Text: NOTICE of Change of Address by Helena C. Rychlicki (Rychlicki, Helena) |
| Nov 24, 2020 | 89 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, RedHill Biopharma Inc..(Silver, Daniel) |
| Oct 16, 2020 | 86 | Notice (Other) (3) Docket Text: NOTICE of Change of Firm Affiliation by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, RedHill Biopharma Inc. (Silver, Daniel) |
| Oct 16, 2020 | 87 | Motion to Amend/Correct (5) Docket Text: Unopposed MOTION to Amend the Scheduling Order - filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc.. (Rychlicki, Helena) Modified on 10/16/2020 (nms). |
| Oct 16, 2020 | 88 | Order (5) Docket Text: SO ORDERED Granting (D.I. 75 in 18-cv-2010-RGA; D.I. 56 in 19-cv-2113-RGA; D.I. 87 in 18-cv-2051-RGA) Unopposed MOTION to Amend the Scheduling Order (Reset Deadlines/Hearings: Fact Discovery completed by 7/23/2021, a 3 day Bench Trial is set to start 6/13/2022, at 8:30 AM in Courtroom 6A, A Pretrial Conference is set for 5/27/2022, at 9:00 AM in Courtroom 6A) (see Order for further details). Signed by Judge Richard G. Andrews on 10/16/2020. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA, 1:19-cv-02113-RGA(nms) |
| Oct 12, 2020 | 85 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Apotex's and MSN's Notice of Deposition Pursuant to Federal Rules of Civil Procedure 30(b)(6) to AstraZeneca AB, AstraZeneca Pharmaceuticals LP., Nektar Therapeutics, and Redhill Biopharma Inc filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc..(Rychlicki, Helena) |
| Oct 6, 2020 | 84 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of MSN's Responses and Objection to Plaintiffs' Second Set of Requests for Production (Nos. 72-87), and MSN's Responses and Objections to Plaintiffs' Second Set of Interrogatories (No.8) filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc..(Rychlicki, Helena) |
| Oct 5, 2020 | 83 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of MSN's Responses and Objection to Plaintiff's Notice of Rule 30 (B)(6) Deposition filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc..(Rychlicki, Helena) |
| Sep 24, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Per counsel's request, DI# 77 description has been corrected to reflect the actual document filed. (cna, ) |
| Sep 23, 2020 | 77 | Notice to Take Deposition (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition of Tesfai Sebhatu filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc.. (Rychlicki, Helena) Modified on 9/24/2020 (cna, ). |
| Sep 23, 2020 | 78 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition of Carl-Johan Aurell filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc..(Rychlicki, Helena) |
| Sep 23, 2020 | 79 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition of Eric Healy filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc..(Rychlicki, Helena) |
| Sep 23, 2020 | 80 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition of David Jensen filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc..(Rychlicki, Helena) |
| Sep 23, 2020 | 81 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition of Anthony Chong filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc..(Rychlicki, Helena) |
| Sep 23, 2020 | 82 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition of Catherine Datto filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc..(Rychlicki, Helena) |
| Sep 15, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [76] MOTION for Pro Hac Vice Appearance of Attorney Michael Furrow and April Abele Isaacson, filed by Nektar Therapeutics, RedHill Biopharma Inc., AstraZeneca Pharmaceuticals LP, AstraZeneca AB. Signed by Judge Richard G. Andrews on 9/15/2020. (nms) |
| Sep 15, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Michael E. Furrow for AstraZeneca AB, for AstraZeneca Pharmaceuticals LP, for Nektar Therapeutics,for RedHill Biopharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (Associated cases: 18-cv2010, 19-cv2113 (myr) |
| Sep 15, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney April Abele Isaacson for AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics and RedHill Biopharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Sep 14, 2020 | 76 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael Furrow and April Abele Isaacson - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, RedHill Biopharma Inc.. (Attachments: # (1) Certifications)(Silver, Daniel) Modified on 9/15/2020 (nms). |
| Sep 14, 2020 | 76 | Certifications for Michael Furrow & April Abele Isaacson (2) |
| Sep 4, 2020 | 75 | Notice of Service (2) Docket Text: NOTICE Of Service of (1) Plaintiffs Second Set of Requests for Production to Defendants Msn Pharmaceuticals, Inc., and Msn Laboratories Pvt Ltd. And (2) Plaintiffs Second Set of Interrogatories to Defendants Msn Pharmaceuticals, Inc. and Msn Laboratories Pvt Ltd., filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, RedHill Biopharma Inc..(Silver, Daniel) Modified on 9/8/2020 (nms). |
| Sep 1, 2020 | 74 | Transcript (23) Docket Text: Official Transcript of Markman Hearing Videoconference held on 08/19/20 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/22/2020. Redacted Transcript Deadline set for 10/2/2020. Release of Transcript Restriction set for 11/30/2020. (Triozzi, Heather) |
| Aug 19, 2020 | N/A | Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Markman Hearing held on 8/19/2020. Counsel for Plaintiffs: D. Silver. Counsel for Defendants: H. Rychlicki, C. Hitch. (Court Reporter Heather Triozzi.) Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA, 1:19-cv-02113-RGA (lak) |
| Aug 7, 2020 | N/A | Remark (0) Docket Text: Remark: The dial-in information for the August 19, 2020 Markman hearing is as follows: 1-202-503-1666 Conference ID: 980866230#. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA, 1:19-cv-02113-RGA(lak) |
| Aug 3, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Markman hearing scheduled for August 19, 2020, will be held using Skype for business. A joint email with the email addresses for all those participating in the hearing shall be due to the Court's Case Manager by 4:00 PM on 8/7/2020. Ordered by Judge Richard G. Andrews on 8/3/2020. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA, 1:19-cv-02113-RGA(nms) |
| Jul 15, 2020 | 71 | Joint Claim Construction Brief (30) Docket Text: Joint Claim Construction Brief, filed by AstraZeneca AB, RedHill Biopharma Inc., Nektar Therapeutics, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) Modified on 7/16/2020 (nms). |
| Jul 15, 2020 | 72 | Appendix (4) Docket Text: Joint Appendix re [71] Joint Claim Construction Brief, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, RedHill Biopharma Inc.. (Attachments: # (1) Exhibits part 1, # (2) Exhibits part 2, # (3) Exhibits part 3, # (4) Exhibits part 4)(Silver, Daniel) Modified on 7/16/2020 (nms). |
| Jul 15, 2020 | 72 | Exhibit 1-24 (Pt. 1 of 4) (243) |
| Jul 15, 2020 | 72 | Exhibit 1-24 (Pt. 2 of 4) (148) |
| Jul 15, 2020 | 72 | Exhibit 1-24 (Pt. 3 of 4) (189) |
| Jul 15, 2020 | 72 | Exhibit 1-24 (Pt. 4 of 4) (131) |
| Jun 18, 2020 | 70 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, and RedHill Biopharma Inc.s Second Amended Disclosures Pursuant to the District of Delawares Default Standard for Discovery; (2) AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, and RedHill Biopharma Inc.s Second Amended Rule 26(a) Disclosures; and (3) Plaintiffs Second Supplemental Objections and Responses to Defendants Interrogatory No. 1 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, RedHill Biopharma Inc..(Silver, Daniel) |
| Jun 11, 2020 | 67 | Order (4) Docket Text: SO ORDERED Granting (60 in 18-cv-2010-RGA; 65 in 18-cv-2051-RGA; 37 in 19-cv-2113-RGA) Stipulation and Order to Amend Case Schedule. Signed by Judge Richard G. Andrews on 6/11/2020. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA, 1:19-cv-02113-RGA(nms) |
| Jun 11, 2020 | 68 | Order (3) Docket Text: ORDER Granting (66 in 18-cv-2051-RGA; 61 in 18-cv-2010-RGA; 38 in 19-cv-2113-RGA) MOTION to Join Plaintiff and Amend Case Caption (*RedHill Biopharma Inc. added). Signed by Judge Richard G. Andrews on 6/11/2020. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA, 1:19-cv-02113-RGA(nms) |
| Jun 11, 2020 | 69 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent RedHill Biopharma Ltd. for RedHill Biopharma Inc. filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, RedHill Biopharma Inc.. (Silver, Daniel) |
| Jun 9, 2020 | 65 | Stipulation (4) Docket Text: STIPULATION and [Proposed] Order to Amend Case Schedule by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Silver, Daniel) |
| Jun 9, 2020 | 66 | Motion for Miscellaneous Relief (4) Docket Text: MOTION to Join Plaintiff and Amend Case Caption - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Attachments: # (1) Proposed Order, # (2) 7.1.1. Certification)(Silver, Daniel) Modified on 6/10/2020 (nms). |
| Jun 9, 2020 | 66 | Text of Proposed Order (3) |
| Jun 9, 2020 | 66 | Rule 7.1.1. Certification (1) |
| Jun 8, 2020 | 64 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Reply Claim Construction Brief and Exhibits filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics.(Silver, Daniel) |
| Apr 29, 2020 | 63 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Supplemental Invalidity Contentions Pursuant to Delaware Default Standard Rule 4(d) filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc..(Rychlicki, Helena) |
| Apr 13, 2020 | 62 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs Opening Claim Construction Brief and (2) Declaration of Dr. Allan Myerson In Support of Plaintiffs Opening Claim Construction Brief filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics.(Silver, Daniel) |
| Apr 8, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Angelica H. Nguyen for AstraZeneca AB, AstraZeneca Pharmaceuticals LP and Nektar Therapeutics added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA, 1:19-cv-02113-RGA(mal) |
| Apr 7, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (61 in 18-cv-2051-RGA; 25 in 19-cv-2113-RGA; 57 in 18-cv-2010-RGA) MOTION for Pro Hac Vice Appearance of Attorney Angelica H. Nguyen, filed by Nektar Therapeutics, AstraZeneca Pharmaceuticals LP, AstraZeneca AB. Signed by Judge Richard G. Andrews on 4/7/2020. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA, 1:19-cv-02113-RGA(nms) |
| Apr 7, 2020 | 61 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Angelica H. Nguyen - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Attachments: # (1) Certification for Angelica H. Nguyen)(Silver, Daniel) |
| Apr 7, 2020 | 61 | Certification for Angelica H. Nguyen (1) |
| Apr 1, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (60 in 18-cv-2051-RGA; 56 in 18-cv-2010-RGA; 23 in 19-cv-2113-RGA) Stipulation and Proposed Order for Extension of Time Regarding Claim Construction Briefing. Signed by Judge Richard G. Andrews on 4/1/2020. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA, 1:19-cv-02113-RGA(nms) |
| Mar 31, 2020 | 60 | Stipulation (4) Docket Text: STIPULATION For Extension of Time Regarding Claim Construction Briefing, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Joyce, Alexandra) Modified on 4/1/2020 (nms). |
| Mar 6, 2020 | 59 | Claim Construction Chart (10) Docket Text: Supplemental Joint Claim Construction Statement, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Attachments: # (1) Appendix C)(Silver, Daniel) Modified on 3/12/2020 (nms). |
| Mar 6, 2020 | 59 | Appendix C (53) |
| Feb 3, 2020 | 58 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of MSN'S Responses and Objections to Plaintiffs First Set of Interrogatories filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc..(Rychlicki, Helena) |
| Jan 28, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Counsel are to advise on or before Tuesday, February 11, 2020, by email to Judge Thynge, with a copy to her Judicial Administrator, Ms. Kennedy, as well as opposing counsel, their clients interest in mediation and the timing when mediation is preferred with a very brief explanation why. Ordered by Chief Magistrate Judge Mary Pat Thynge on 1/28/20. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA(cak) |
| Jan 28, 2020 | 57 | Order (4) Docket Text: SO ORDERED Granting (D.I. 12 in 19-cv-2113-RGA; D.I. 53 in 18-cv-2051-RGA; D.I. 48 in 18-cv-2010-RGA) Stipulation and Order Regarding Scheduling (*Reset Deadlines: Joint Claim Construction Brief due by 7/15/2020, Fact Discovery completed by 8/28/2020; A Bench Trial is set for 9/20/2021, at 8:30 AM in Courtroom 6A; A Markman Hearing is set for 8/19/2020, at 9:00 AM in Courtroom 6A; A Pretrial Conference is set for 9/10/2021, at 2:00 PM in Courtroom 6A) (see Order for further details). Signed by Judge Richard G. Andrews on 1/28/2020. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA, 1:19-cv-02113-RGA(nms) |
| Jan 23, 2020 | 55 | Order (3) Docket Text: SO ORDERED Granting (D.I. 49 in 18-cv-2010-RGA; D.I. 54 in 18-cv-2051-RGA) Stipulation and Proposed Order Regarding Deposition Limits. Signed by Judge Richard G. Andrews on 1/23/2020. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA(nms) |
| Jan 22, 2020 | 53 | Stipulation (4) Docket Text: STIPULATION and [Proposed] Order Regarding Scheduling by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Jan 22, 2020 | 54 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order Regarding Deposition Limits by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Jan 15, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 52 in 18-cv-2051-RGA; D.I. 47 in 18-cv-2010-RGA) STIPULATION and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 1/15/2020. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA(nms) |
| Jan 14, 2020 | 52 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Silver, Daniel) Modified on 1/15/2020 (nms). |
| Jan 9, 2020 | 51 | Redacted Document (9) Docket Text: REDACTED VERSION of [50] Notice to Take Deposition by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Silver, Daniel) |
| Jan 2, 2020 | 49 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) AstraZeneca AB, AstraZeneca Pharmaceuticals LP, and Nektar Therapeutics First Amended Disclosures Pursuant to the District of Delaware Default Standard for Discovery, (2) Plaintiffs First Set of Interrogatories to Defendants, and (3) AstraZeneca AB, AstraZeneca Pharmaceuticals LP, and Nektar Therapeutics First Amended Rule 26(a) Disclosures filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics.(Silver, Daniel) |
| Dec 16, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (48 in 18-cv-2051-RGA; 42 in 18-cv-2010-RGA) STIPULATION TO EXTEND TIME to Submit a Stipulation or Otherwise Initiate the Court's Discovery Dispute Resolution Mechanism on the Limits for Depositions to January 15, 2020. Signed by Judge Richard G. Andrews on 12/16/2019. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA(nms) |
| Dec 13, 2019 | 48 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Silver, Daniel) Modified on 12/15/2019 (nms). |
| Nov 22, 2019 | 47 | Claim Construction Chart (9) Docket Text: Joint Claim Construction Chart, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Attachments: # (1) Appendix C)(Silver, Daniel) Modified on 11/25/2019 (nms). |
| Nov 22, 2019 | 47 | Appendix C (53) |
| Nov 14, 2019 | 46 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs First Supplemental Objections and Responses to Defendants Interrogatory No. 1 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics.(Silver, Daniel) |
| Nov 1, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (38 in 18-cv-2010-RGA; 45 in 18-cv-2051-RGA) STIPULATION TO EXTEND TIME Joint Claim Construction Chart to November 22, 2019. Signed by Judge Richard G. Andrews on 11/1/2019. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA(nms) |
| Nov 1, 2019 | 45 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME Joint Claim Construction Chart to November 22, 2019 - filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc.. (Rychlicki, Helena) |
| Oct 22, 2019 | 43 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Apotex's and MSN's Identification of Claim Terms in Need of Construction and Proposed Constructions filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc..(Rychlicki, Helena) |
| Oct 22, 2019 | 44 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs Supplemental Claim Constructions filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics.(Silver, Daniel) |
| Oct 10, 2019 | 41 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' List of Proposed Claim Terms for Construction filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Joyce, Alexandra) |
| Oct 10, 2019 | 42 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Identification of Claim Terms in Need of Construction and Proposed Constructions re SO ORDERED, filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc..(Rychlicki, Helena) |
| Oct 2, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (34 in 18-cv-2010-RGA; 40 in 18-cv-2051-RGA) STIPULATION TO EXTEND TIME to Exchange claim terms and proposed constructions to October 10, 2019. Signed by Judge Richard G. Andrews on 10/2/2019. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA(nms) |
| Oct 1, 2019 | 40 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Exchange claim terms and proposed constructions to October 10, 2019 - filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc.. (Rychlicki, Helena) |
| Jul 10, 2019 | 39 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs Objections and Responses to the MSN Defendants First Set of Interrogatories (No. 1) and (2) Plaintiffs Objections and Responses to Defendants First Set of Requests for Production of Documents and Things (Nos. 1-87) filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics.(Silver, Daniel) |
| Jul 8, 2019 | 38 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Paragraph 4(d) Disclosures filed by Apotex Corp., Apotex Inc..(Dorsney, Kenneth) |
| Jun 24, 2019 | 37 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Responses and Objections to Plaintiffs' First Set of Requests for Production (Nos. 1-71) filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc..(Rychlicki, Helena) |
| Jun 10, 2019 | 36 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of MSN Defendants' First Set of Interrogatories (No. 1) and MSN Defendants' First Set of Requests for Production of Documents and Things (Nos. 1-87) filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc..(Rychlicki, Helena) |
| Jun 7, 2019 | 35 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of AstraZeneca AB, AstraZeneca Pharmaceuticals LP, and Nektar Therapeutics Initial Infringement Contentions Pursuant to the District of Delawares Default Standard for Discovery filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics.(Silver, Daniel) |
| Jun 4, 2019 | 34 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Section 4.b. Disclosures Pursuant to District of Delaware's Default Standard for Discovery filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc..(Rychlicki, Helena) |
| May 29, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [33] MOTION for Pro Hac Vice Appearance of Attorney Kaveh V. Saba, filed by MSN Pharmaceuticals, Inc., MSN Laboratories Pvt. Ltd.. Signed by Judge Richard G. Andrews on 5/29/2019. (nms) |
| May 29, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kaveh Saba, Matthew C. Ruedy, Jeremy J. Edwards, and Steven A. Maddox for MSN Laboratories Pvt. Ltd. and MSN Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| May 28, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [28] MOTION for Pro Hac Vice Appearance of Attorney Steven A. Maddox, filed by MSN Pharmaceuticals, Inc., MSN Laboratories Pvt. Ltd., [30] MOTION for Pro Hac Vice Appearance of Attorney Matthew C. Ruedy, filed by MSN Pharmaceuticals, Inc., MSN Laboratories Pvt. Ltd., [29] MOTION for Pro Hac Vice Appearance of Attorney Jeremy J. Edwards, filed by MSN Pharmaceuticals, Inc., MSN Laboratories Pvt. Ltd.. Signed by Judge Richard G. Andrews on 5/28/2019. (nms) |
| May 28, 2019 | 28 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Steven A. Maddox - filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc.. (Attachments: # (1) Certification)(Rychlicki, Helena) |
| May 28, 2019 | 28 | Certification (1) |
| May 28, 2019 | 29 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jeremy J. Edwards - filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc.. (Attachments: # (1) Certification)(Rychlicki, Helena) |
| May 28, 2019 | 29 | Certification (1) |
| May 28, 2019 | 30 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Matthew C. Ruedy - filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc.. (Attachments: # (1) Certification)(Rychlicki, Helena) |
| May 28, 2019 | 30 | Certification (1) |
| May 28, 2019 | 31 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kaveh V. Saba - filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc.. (Attachments: # (1) Certification)(Rychlicki, Helena) |
| May 28, 2019 | 31 | Certification (1) |
| May 28, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The MOTION for Pro Hac Vice Appearance of Attorney Kaveh V. Saba (D.I. 31) is DENIED without prejudice to renew. Certifications by counsel need to be dated as to the date they were signed. Ordered by Judge Richard G. Andrews on 5/28/2019. (nms) |
| May 28, 2019 | 33 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kaveh V. Saba - filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc.. (Attachments: # (1) Certification)(Rychlicki, Helena) |
| May 28, 2019 | 33 | Certification (1) |
| May 24, 2019 | 27 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs First Set of Requests for Production to Defendants MSN Pharmaceuticals, Inc., and MSN Laboratories Pvt. Ltd.; (2) Plaintiffs Objections and Responses to Defendants First Set of Joint Interrogatories (Nos. 1-3) filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics.(Silver, Daniel) |
| May 23, 2019 | 26 | Notice of Substitution of Counsel (2) Docket Text: NOTICE OF SUBSTITUTION OF COUNSEL re MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc.: Entry of appearance of attorney Helena C. Rychlicki. Attorney Stuart D. Sender and Andrew J. Miller terminated. (Rychlicki, Helena) |
| Apr 24, 2019 | 25 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants Apotex's and MSN's First Set of Joint Interrogatories filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc..(Rychlicki, Helena) |
| Apr 9, 2019 | 24 | Order (25) Docket Text: SO ORDERED Granting (22 in 118-cv-2051-RGA, 22 in 18-cv-2010-RGA) Stipulated Protective Order. Signed by Judge Richard G. Andrews on 4/9/2019. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA(nms) |
| Apr 8, 2019 | 22 | Proposed Order (25) Docket Text: PROPOSED Protective Order, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Silver, Daniel) Modified on 4/9/2019 (nms). |
| Apr 8, 2019 | 23 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) AstraZeneca AB, AstraZeneca Pharmaceuticals LP, and Nektar Therapeutics Section 4.a. Disclosures Pursuant to the District of Delawares Default Standard for Discovery; and (2) AstraZeneca AB, AstraZeneca Pharmaceuticals LP, and Nektar Therapeutics Initial Disclosures Pursuant to the District of Delawares Default Standard for Discovery filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics.(Silver, Daniel) |
| Mar 28, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (21 in 18-cv-2010-RGA, 21 in 18-cv-2051-RGA) STIPULATION TO EXTEND the deadline to submit a proposed Protective Order to April 10, 2019. Signed by Judge Richard G. Andrews on 3/27/2019. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA(nms) |
| Mar 27, 2019 | 21 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME The Deadline to Submit a Proposed Protective Order to April 10, 2019 - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Silver, Daniel) |
| Mar 20, 2019 | 19 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Initial Disclosures filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc..(Rychlicki, Helena) |
| Mar 20, 2019 | 20 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of AstraZeneca AB, AstraZeneca Pharmaceuticals LP, and Nektar Therapeutics Initial Disclosures filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics.(Silver, Daniel) |
| Mar 12, 2019 | 18 | Transcript (17) Docket Text: Official Transcript of Scheduling Conference held on 3/1/19 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather Triozzi,Telephone number 302-573-6195. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 4/2/2019. Redacted Transcript Deadline set for 4/12/2019. Release of Transcript Restriction set for 6/10/2019. (Triozzi, Heather) |
| Mar 6, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (cak) |
| Mar 6, 2019 | 17 | Scheduling Order (8) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 8/16/2019. Amended Pleadings due by 8/16/2019. Fact Discovery completed by 3/31/2020. Joint Claim Construction Brief due by 5/29/2020. A Markman Hearing is set for 6/25/2020, at 9:00 AM in Courtroom 6A before. A Pretrial Conference is set for 2/19/2021, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set to start 3/1/2021, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 3/6/2019. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA(nms) |
| Mar 5, 2019 | 16 | Proposed Order (8) Docket Text: PROPOSED Scheduling Order, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Silver, Daniel) Modified on 3/6/2019 (nms). |
| Mar 1, 2019 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 3/1/2019. Local counsel present for Plaintiff: D. Silver. Local counsel Present for Defendants: K. Dorsney, H. Rychlicki. (Court Reporter Heather Triozzi.) Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA(crb) |
| Feb 27, 2019 | 15 | Proposed Order (9) Docket Text: PROPOSED Scheduling Order, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Silver, Daniel) Modified on 2/27/2019 (nms). |
| Jan 25, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Sumeet P. Dang for AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
| Jan 24, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] MOTION for Pro Hac Vice Appearance of Attorney Jessamyn S. Berniker, Aaron P. Maurer, Sumeet P. Dang, filed by Nektar Therapeutics, AstraZeneca Pharmaceuticals LP, AstraZeneca AB, and [13] MOTION for Pro Hac Vice Appearance of Attorney Stuart D. Sender, Esq., filed by MSN Pharmaceuticals, Inc., MSN Laboratories Pvt. Ltd.. Signed by Judge Richard G. Andrews on 1/24/2019. (nms) |
| Jan 24, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Aaron P. Maurer for AstraZeneca AB, AstraZeneca Pharmaceuticals LP, and Nektar Therapeutics added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA(ddp) |
| Jan 24, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Stuart D. Sender for MSN Laboratories Pvt. Ltd. and MSN Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ddp) |
| Jan 24, 2019 | 14 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 3/1/2019, at 4:15 PM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 1/24/2019. (nms) |
| Jan 23, 2019 | 12 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jessamyn S. Berniker, Aaron P. Maurer, Sumeet P. Dang - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Attachments: # (1) Certifications)(Silver, Daniel) Modified on 1/24/2019 (nms). |
| Jan 23, 2019 | 12 | Jessamyn S. Berniker, Aaron P. Maurer, Sumeet P. Dang (3) |
| Jan 23, 2019 | 13 | Motion for Leave to Appear Pro Hac Vice (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Stuart D. Sender, Esquire - filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc.. (Attachments: # (1) Certification, # (2) Certificate of Service)(Rychlicki, Helena) |
| Jan 23, 2019 | 13 | Certification (1) |
| Jan 23, 2019 | 13 | Certificate of Service (1) |
| Jan 17, 2019 | 9 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Helena C. Rychlicki on behalf of All Defendants (Attachments: # (1) Certificate of Service)(Rychlicki, Helena) |
| Jan 17, 2019 | 9 | Certificate of Service (1) |
| Jan 17, 2019 | 10 | Answer to Complaint (17) Docket Text: ANSWER to [1] Complaint, by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc.. (Attachments: # (1) Certificate of Service)(Rychlicki, Helena) |
| Jan 17, 2019 | 10 | Certificate of Service (1) |
| Jan 17, 2019 | 11 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate MSN Laboratories Pvt. Ltd. for MSN Pharmaceuticals, Inc.; Corporate Parent MSN Pharmaceuticals, Inc. for MSN Laboratories Pvt. Ltd. filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc.. (Rychlicki, Helena) |
| Jan 3, 2019 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by AstraZeneca AB, Nektar Therapeutics, AstraZeneca Pharmaceuticals LP. MSN Pharmaceuticals, Inc. served on 12/27/2018, answer due 1/17/2019. (Silver, Daniel) |
| Jan 3, 2019 | 8 | Declaration (2) Docket Text: DECLARATION of Mailing regarding service on MSN Laboratories Pvt. Ltd. on December 27, 2018, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Attachments: # (1) Exhibits A-B)(Silver, Daniel) Modified on 1/3/2019 (nms). |
| Jan 3, 2019 | 8 | Exhibit A & B (6) |
| Jan 2, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Dec 27, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to MSN Laboratories Pvt. Ltd. on 12/27/2018; MSN Pharmaceuticals, Inc. on 12/27/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (rwc) |
| Dec 26, 2018 | 1 | Exhibit A (20) |
| Dec 26, 2018 | 1 | Civil Cover Sheet (1) |
| Dec 26, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc) |
| Dec 26, 2018 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/14/18. Date of Expiration of Patent: 4/4/32.Thirty Month Stay Deadline: 5/14/2021. (rwc) |
| Dec 26, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,012,469. (rwc) |
| Dec 26, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB, AstraZeneca Pharmaceuticals LP filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (rwc) |
| Dec 26, 2018 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Primecap Management Company, Corporate Parent Fidelity Management and Research LLC, Corporate Parent Vanguard Group for Nektar Therapeutics filed by Nektar Therapeutics. (rwc) |
| Dec 26, 2018 | 1 | Complaint* (1) |
